Xeljanz Study Raises Some Concerns About Heart and Cancer Risks: What Patients Need to Know
The medication, used to treat rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis, already had a boxed warning for blood clots, infection, and certain cancers. Now more research is needed to understand potential additional risks.
Continue reading